Clinical Impact of TP53 Mutations in Patients with MDS and Isolated Deletion 5(q) Treated with Lenalidomid: Results from the German Prospective Le-Mon-5 Trial

ISSN
1528-0020
0006-4971
Date Issued
2014
Author(s)
Mossner, Maximilian
Jann, Johann Christoph
Launiger-Loersch, Evi
Nowak, Daniel
Platzbecker, Uwe
Giagounidis, Aristoteles A. N.
Goetze, Katharina S.
Letsch, Anne
Schlenk, Richard F.
Haferlach, Torsten
Bug, Gesine
Luebbert, Michael
Ganser, Arnold
Nowak, Verena
Pressler, Jovita
Oblaender, Julia
Fey, Stephanie
Mueller, Nadine
Metzgeroth, Georgia
Hofmann, Wolf-Karsten
Germing, Ulrich
Nolte, Florian